GlaxoSmithKline (GSK,GSK.L) announced that it has entered into a definitive agreement through which GSK will acquire Bristol-Myers Squibb Pakistan (Private) Ltd. and certain associated trademarks for approximately $36.5 million or £24.6 million. Completion of the acquisition is expected by early next year.
GSK noted that it will acquire a portfolio of over 30 well-established pharmaceutical brands. The Bristol-Myers product portfolio, which includes antibiotics, vitamins and dermatology products is complementary to GSK's existing portfolio. Total sales of the Bristol-Myers product portfolio in 2007 were PKR1.5bn or approximately $19 million.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.